JPRN-UMIN000046186
Recruiting
未知
An Observational Study of Follow-up for Symptomatic Adverse Events Using ePRO in Gastrointestinal Cancer Patients after Starting Oral Anticancer Therapy in Pharmacy - FORECAST study
Hachioji Pharmaceutical Center Pharmacy0 sites77 target enrollmentNovember 25, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- colon cancer, gastric cancer, pancreas cancer, biliary tract cancer
- Sponsor
- Hachioji Pharmaceutical Center Pharmacy
- Enrollment
- 77
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Severe mental illness 2\. have cognitive impairment that may affect their ability to complete the questionnaire 3\. Native language is not Japanese
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An observational study of symptomatic adverse events and health-related quality of life (HR-QoL) with the use of patient-reported outcome (PRO) in nivolumab therapy for gastric cancergastric cancerJPRN-UMIN000037433St.Marianna University School of Medicine30
Completed
Not Applicable
Retrospective observational study in patients with renal cell carcinoma treated by everolimus, mTOR inhibitorAdvanced renal cell carcinomaJPRN-UMIN000004730Department of Urology, Kinki University School of Medicine300
Not yet recruiting
Not Applicable
A Retrospective Study on the Post-Treatment Symptoms and Prognosis of Game Over-used PatientsKCT0003799Chung-Ang Univerisity Hospital500
Completed
Not Applicable
Asymptomatic Lumbar Facetal osteoarthritisHealth Condition 1: null- Patients coming for MDCT for abdominal and urological lesionsCTRI/2018/05/013688BPS GMC Khanpur100
Not yet recruiting
Not Applicable
Study evaluating Symptom and Distress screening tools in initiating early supportive care in cancer patients treated with curative radiation therapyHealth Condition 1: C00-D49- NeoplasmsCTRI/2022/01/039478Debnarayan Dutta